169 related articles for article (PubMed ID: 18405371)
21. Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer.
Lebrecht A; Ludwig E; Huber A; Klein M; Schneeberger C; Tempfer C; Koelbl H; Hefler L
Gynecol Oncol; 2002 Apr; 85(1):32-5. PubMed ID: 11925116
[TBL] [Abstract][Full Text] [Related]
22. Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer.
Mathur SP; Mathur RS; Underwood PB; Kohler MF; Creasman WT
Gynecol Oncol; 2003 Dec; 91(3):486-93. PubMed ID: 14675666
[TBL] [Abstract][Full Text] [Related]
23. Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer.
Mathur SP; Mathur RS; Young RC
Am J Reprod Immunol; 2000 Oct; 44(4):222-30. PubMed ID: 11076094
[TBL] [Abstract][Full Text] [Related]
24. Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy.
Ankersmit HJ; Moser B; Roedler S; Teufel I; Zuckermann A; Roth G; Lietz K; Back C; Gerlitz S; Wolner E; Boltz-Nitulescu G
Clin Exp Immunol; 2002 Jan; 127(1):183-9. PubMed ID: 11882051
[TBL] [Abstract][Full Text] [Related]
25. Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors.
Kondera-Anasz Z; Mielczarek-Palacz A; Sikora J
Apoptosis; 2005 Oct; 10(5):1143-9. PubMed ID: 16151647
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
[TBL] [Abstract][Full Text] [Related]
27. Soluble CD95 concentrations are increased in patients with severe systemic lupus erythematosus, but not in their first degree relatives.
van der Linden MW; van Lopik T; Aarden LA; Westendorp RG; Huizinga TW
Ann Rheum Dis; 2001 Mar; 60(3):237-41. PubMed ID: 11171685
[TBL] [Abstract][Full Text] [Related]
28. The Relationship between the Serum Level of Selenium and Cervical Intraepithelial Neoplasia: A Comparative Study in a Population of Nigerian Women.
Obhielo E; Ezeanochie M; Olokor O O; Okonkwo A; Gharoro E
Asian Pac J Cancer Prev; 2019 May; 20(5):1433-1436. PubMed ID: 31127904
[TBL] [Abstract][Full Text] [Related]
29. Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients.
Kimura M; Tomita Y; Imai T; Saito T; Katagiri A; Tanikawa T; Takeda M; Takahashi K
Br J Cancer; 1999 Jul; 80(10):1648-51. PubMed ID: 10408413
[TBL] [Abstract][Full Text] [Related]
30. Mannose-Binding Lectin Does Not Act as a Biomarker for the Progression of Preinvasive Lesions of Invasive Cervical Cancer.
Maestri CA; Nisihara R; Ramos GP; Weinschutz Mendes H; Messias-Reason I; de Carvalho NS
Med Princ Pract; 2017; 26(6):530-534. PubMed ID: 29131134
[TBL] [Abstract][Full Text] [Related]
31. Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker.
Yang S; Cheng H; Huang Z; Wang X; Wan Y; Cai J; Wang Z
Dis Markers; 2015; 2015():506428. PubMed ID: 25873749
[TBL] [Abstract][Full Text] [Related]
32. Carbon monoxide promotes Fas/CD95-induced apoptosis in Jurkat cells.
Song R; Zhou Z; Kim PK; Shapiro RA; Liu F; Ferran C; Choi AM; Otterbein LE
J Biol Chem; 2004 Oct; 279(43):44327-34. PubMed ID: 15280387
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes.
Contreras DN; Krammer PH; Potkul RK; Bu P; Rossi JL; Kaufmann AM; Gissmann L; Qiao L
J Immunother; 2000 Jan; 23(1):67-74. PubMed ID: 10687139
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy.
Ehrlich S; Haas J; Zipp F; Infante-Duarte C
J Neurol Sci; 2007 Jan; 252(1):83-7. PubMed ID: 17169375
[TBL] [Abstract][Full Text] [Related]
35. [The levels of soluble CD95 antigen and CD95+ mononuclear cells in patients with chronic obstructive lung diseases].
Kubysheva NI; Postnikova LB; Presniakova NB; Novikov VV
Klin Lab Diagn; 2009 Mar; (3):22-3. PubMed ID: 19391241
[TBL] [Abstract][Full Text] [Related]
36. Proapoptotic CD95L levels in normal human serum and sera of breast cancer patients.
Olimón-Andalón V; Aguilar-Lemarroy A; Ratkovich-González S; Uribe-López A; Mariscal-Ramírez I; Delgadillo-Cristerna R; Ortiz-Lazareno P; Hernández-Flores G; de Celis R; Bravo-Cuellar A; Jave-Suárez LF
Tumour Biol; 2015 May; 36(5):3669-78. PubMed ID: 25557789
[TBL] [Abstract][Full Text] [Related]
37. Fas, ceramide and serum withdrawal induce apoptosis via a common pathway in a type II Jurkat cell line.
Caricchio R; D'Adamio L; Cohen PL
Cell Death Differ; 2002 May; 9(5):574-80. PubMed ID: 11973615
[TBL] [Abstract][Full Text] [Related]
38. Prognostic utility of serum YKL-40 in patients with cervical cancer.
Roslind A; Palle C; Johansen JS; Christensen IJ; Nielsen HJ; Mosgaard BJ
Scand J Clin Lab Invest; 2020 Dec; 80(8):687-693. PubMed ID: 33186077
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer.
Kong Q; Tang Z; Xiang F; Jiang J; Yue H; Wu R; Kang X
Clin Lab; 2017 Feb; 63(2):335-340. PubMed ID: 28182350
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of T-cell CD3-zeta chains in patients with cervical dysplasia before and after treatment.
Shondel SM; Helm CW; Gercel-Taylor C; Taylor DD
Int J Gynecol Cancer; 2007; 17(6):1278-82. PubMed ID: 17997796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
